do glp 1 cause cancer Risk of pancreatic associated with GLP-1 receptor agonist therapy From Diabetes to Oncology: Glucagon-like
Description
MedTech stocks continue to feel pressure from glucagon-like peptide-1 (GLP-1) drugs for obesity, based primarily on speculation, and despite strong third-quarter performances from many firms in this sector
Results Despite heterogeneity in study designs and populations, a largely consistent association was found between GLP-1RA use and a reduced incidence of glaucoma
See our FAQ page for additional product information
Bake at 400F for 22 to 25 minutes
